Publication:
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024

dc.contributor.coauthorKacperczyk-Bartnik, Joanna
dc.contributor.coauthorEl Hajj, Houssein
dc.contributor.coauthorBizzarri, Nicolo
dc.contributor.coauthorZwimpfer, Tibor Andrea
dc.contributor.coauthorStrojna, Aleksandra Natalia
dc.contributor.coauthorGasimli, Khayal
dc.contributor.coauthorAngeles, Martina Aida
dc.contributor.coauthorGhirardi, Valentina
dc.contributor.coauthorErfani, Hadi
dc.contributor.coauthorNikolova, Tanja
dc.contributor.coauthorTheofanakis, Charalampos
dc.contributor.coauthorToth, Richard
dc.contributor.coauthorSebastia, Jordi Ponce
dc.contributor.coauthorChiva, Luis
dc.contributor.coauthorLorusso, Domenica
dc.contributor.departmentGraduate School of Health Sciences
dc.contributor.kuauthorBilir, Esra
dc.contributor.schoolcollegeinstituteGRADUATE SCHOOL OF HEALTH SCIENCES
dc.date.accessioned2024-12-29T09:38:01Z
dc.date.issued2024
dc.description.abstractThe 'Best of ESGO 2024' article includes a selection of the most highly rated original research presented during the 25th Annual Congress of the European Society of Gynaecologic Oncology (ESGO), held in Barcelona, Spain, March 7-10, 2024. Of 1218 asbtracts submitted, 35 studies presented during the best oral sessions, mini oral sessions, best three minute presentations session, and young investigator session were selected by the ESGO abstract committee and the authors of the European Network of Young Gynae Oncologists (ENYGO). There was a strong focus on the surgical treatment of early stage cervical cancer and the management of advanced or recurrent gynecological cancers using induction therapy, immunotherapy, and maintenance therapy. With this work, ENYGO and ESGO aim to focus the attention of clinicians, scientists, patients, and all stakeholders interested in gynecologic oncology on research advances in the field.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue9
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipWe would like to acknowledge all authors who submitted and shared their results during the 25th ESGO Congress. We are also very grateful to the ESGO Office, Lenka Hovorkova, and Tereza Cicakova for continuous support during preparation of Best of ESGO manuscripts.
dc.description.volume34
dc.identifier.doi10.1136/ijgc-2024-005844
dc.identifier.eissn1525-1438
dc.identifier.issn1048-891X
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85199422161
dc.identifier.urihttps://doi.org/10.1136/ijgc-2024-005844
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22559
dc.identifier.wos1274220100001
dc.keywordsCervical cancer
dc.keywordsOvarian cancer
dc.keywordsUterine cancer
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofInternational Journal of Gynecological Cancer
dc.subjectOncology
dc.subjectObstetrics and gynecology
dc.titleBest original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorBilir, Esra
local.publication.orgunit1GRADUATE SCHOOL OF HEALTH SCIENCES
local.publication.orgunit2Graduate School of Health Sciences
relation.isOrgUnitOfPublication2f870f28-12c9-4b28-9465-b91a69c1d48c
relation.isOrgUnitOfPublication.latestForDiscovery2f870f28-12c9-4b28-9465-b91a69c1d48c
relation.isParentOrgUnitOfPublication4c75e0a5-ca7f-4443-bd78-1b473d4f6743
relation.isParentOrgUnitOfPublication.latestForDiscovery4c75e0a5-ca7f-4443-bd78-1b473d4f6743

Files